Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25361
Abstract: To assess the efficacy and the effect of biologic effective dose (BED) on outcomes treated by hypofractionated stereotactic radiotherapy for colorectal cancer (CRC) oligometastases. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Strahlentherapie und Onkologie"
DOI: 10.1007/s00066-021-01757-6
Abstract: Island blocking and dose leakage problems will lead to unnecessary irradiation to normal brain tissue (NBT) in hypofractionated stereotactic radiotherapy (HSRT) for multiple brain metastases (BM) with single-isocenter volumetric modulated arc therapy (VMAT). The present… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2018.08.013
Abstract: Purpose To quantitatively assess volumetric changes after hypofractionated stereotactic radiation therapy (HFSRT) in patients treated for vestibular schwannomas and meningiomas. Methods and materials We retrospectively reviewed records of patients treated with HFSRT at our institution… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique"
DOI: 10.1016/j.canrad.2019.02.004
Abstract: PURPOSE The purpose of the study was to evaluate the outcomes of stereotactic radiation therapy for primary and secondary liver tumours in Jean-Perrin cancer centre (Clermont-Ferrand, France) in terms of efficacy and safety. MATERIALS AND… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique"
DOI: 10.1016/j.canrad.2020.04.011
Abstract: PURPOSE Stereotactic radiotherapy plays a major role in the treatment of brain metastases (BM). We aimed to compare the dosimetric results of four plans for hypofractionated stereotactic radiotherapy (HFSRT) for large brain metastases. MATERIAL AND… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa260
Abstract: BACKGROUND Radiotherapy may synergize with programmed death 1 (PD-1)/PD-1 ligand (PD-L1) blockade. The purpose of this study was to determine the recommended Phase II dose, safety/tolerability, and preliminary efficacy of combining pembrolizumab, an anti-PD-1 monoclonal… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Neuro-oncology"
DOI: 10.1093/neuonc/noz144
Abstract: BACKGROUND The objective was to evaluate the risk and predictors of developing leptomeningeal disease (LMD) in patients with brain metastases treated with 5-fraction hypofractionated stereotactic radiotherapy (HSRT). METHODS Patients treated with HSRT for intact brain… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e14015
Abstract: e14015 Background: The optimal treatment for recurrent glioblastoma (rGBM) remains uncertain. Hypofractionated stereotactic radiotherapy (HSRT) and anti-vascular endothelial growth factor (VEGF) antibodies (e.g, bevacizumab and anlotinib) have been reported a promising survival benefit and acceptable… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Nagoya Journal of Medical Science"
DOI: 10.18999/nagjms.81.3.397
Abstract: ABSTRACT Stereotactic radiosurgery for large brain metastases (BM) not amenable to surgical resection is associated with limited local control and neurotoxicity, while hypofractionated stereotactic radiotherapy (HFSRT) has emerged as a promising option. We retrospectively evaluated… read more here.